• 1
    Bryan CS & Reynold KL. Bacteremic nosocomial pneumonia. Am Rev Respir Dis 1984; 129:66871.
  • 2
    Diasio RB & LoBuglo AF. Immunomodulators: immunosuppressive agents and immunostimulants. In: HardmanJG, LimbirdLE, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill, 1996:1291308.
  • 3
    Fireman P. Combination of inhaled corticosteroids plus other medications in the management of moderate to severe persistent asthma. Allergy Asthma Proc 2000; 21:31522.
  • 4
    Flaherty KR, Toews GB, Lynch JP III et al. Steroids in idopathic pulmonary ficrosis. a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 2001; 110:3268.
  • 5
    Pallillo JE & Fauci AS. Mechanism of glucocorticoid action on immune process. Ann Rev Pharmacol Toxicol 1979; 19:179201.
  • 6
    Fukushima K, Ando M, Suga M, Araki S. Impaired function of polymorphonuclear leukocytes exuded into bronchoalveolar spaces infected with Pseudomonas aeruginosa in steroid-treated rabbits. Exp Lung Res 1987; 13:14155.
  • 7
    Gosselin DD, Esantis J, Boule M, Skamene E, Matouk C, Radzioch D. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun 1995; 63:32728.
  • 8
    Tsai WC, Strieter RM, Zisman DA et al. Nitric oxide is required for protective innate immunity against Klebsiella pneumoniae. Infect Immun 1997; 65:18705.
  • 9
    Yu H, Nasr SZ, Deretic V. Innate lung defence and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratroy infections in cystic fibrosis. Infect Immun 2000; 68:21427.
  • 10
    Greenberger MJ, Strieter RM, Kunkel SL et al. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumoniae. J Infect Dis 1996; 173:15965.
  • 11
    Tsai WC, Strieter RM, Wilkowski JM et al. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J Immunol 1998; 161:243540.
  • 12
    Mukaida N, Morita M, Ishikawa Y et al. Novel mechanism of glucorticoid-mediated gene repression. Nuclear factor-κB is target for glucocorticoid-mediated interleukin-8 gene repression. J Biol Chem 1994; 269:1328995.
  • 13
    Matsusaka T, Fujikawa K, Nishio Y et al. Transcription factors NF-IL 6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993; 90:101937.
  • 14
    Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994; 56:5548.
  • 15
    Blackwell TS & Christman JW. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17:39.
  • 16
    Taylor BS, De Vera ME, Ganster RW et al. Multiple NF-kappa B enhancer elements regulate cytokine induction of human inducible nitric oxide synthase gene. J Biol Chem 1998; 273:1514856.
  • 17
    Trede NS, Tsytsykova AV, Chatila T, Goldfeld AE, Geha RS. Transcriptional activation of the human TNF-α promoter by superantigen in human monocytic cells: role of NF-κB. J Immunol 1995; 155:9028.
  • 18
    Pennington JE & Ehrie MG. Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression. J Infect Dis 1978; 137:76474.
  • 19
    Sonoda F, Oishi K, Iwagaki A, Matsumoto K. Endogenous tumor necrosis factor (TNF) α mediates neutrophil accumulation at the mid-phase of a murine model of Pseudomonas aeruginosa pneumonia. Microbiol Immunol 1997; 41:6018.
  • 20
    Rosselet A, Feihl F, Markert M, Gnaegi A, Perret C, Liaudet L. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxin shock. Am J Respir Crit Care Med 1998; 157:16270.
  • 21
    Southan GJ, Szabo C, Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectively. Br J Pharmacol 1995; 114:5106.
  • 22
    Sonoda Y, Mukaida N, Wang JB et al. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine(s). J Immunol 1998; 160:615965.
  • 23
    Fujioka N, Mukaida N, Harada A et al. Preparation of specific antibodies against murine IL-1 ra and the establishment of IL-1 ra as an endogenous regulator of bacterial-induced fulminant hepatitis in mice. J Leukoc Biol 1995; 58:908.
  • 24
    Amano H, Oishi K, Sonoda F et al. Role of cytokine-induced neutrophil chemoattarctant-2 (CINC-2) α in a rat model of chronic bronchopulmonary infections with Pseudomonas aeruginosa. Cytokine 2000; 12:16628.DOI: 10.1006/cyto.2000.0771
  • 25
    Umezawa K, Akaike T, Fujii S et al. Induction of nirtic oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice. Infect Immun 1997; 65:293140.
  • 26
    De Vera ME, Taylor BS, Wang Q, Shapiro RA, Billiar TR, Geller DA. Dexamethasone suppresses iNOS gene expression by up-regulating I-κBa and inhibiting NF-κB. Am J Physiol 1997; 273:G12906.
  • 27
    Fierro IM, Nascimento-DeSilva V, Arruda MA et al. Induction of NOS in rat PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity. J Leukoc Biol 1999; 65:50814.
  • 28
    Bruneli L, Crow JP, Beckman JS. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch Biochem Biophys 1995; 316:32734.DOI: 10.1006/abbi.1995.1044
  • 29
    Zhu L, Gunn C, Beckman JS. Bactericidal activity of peroxynitrite. Arch Biochem Biophys 1992; 298:4527.
  • 30
    Yoshida K, Akaike T, Doi T et al. Pronounced enhancement of NO-dependent antimicrobial action by an NO-oxydizing agent, imidazolineoxyl N-oxide. Infect Immun 1993; 61:35525.
  • 31
    Akaike T, Noguchi Y, Ijiri S et al. Pathogenesis of influenza-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996; 93:244853.
  • 32
    Kooy NW, Royall JA, Ye YE, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151:12504.
  • 33
    Yoo HS, Rutherford MS, Maheswaran SK, Srinand S, Ames TR. Induction of nitric oxide by bovine alveolar macrophages in response to Pasteurella haemollytica A1. Microb Pathog 1996; 20:36175.
  • 34
    Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces inducible nitric oxide synthase in human neutrophils. J Clin Invest 1997; 99:1106.
  • 35
    Meng QH, Polak JM, Edgar AJ et al. Neutrophils enhance expression of inducible nitric oxide synthase in human normal but not cystic fibrosis bronchial epithelial cells. J Pathol 2000; 190:12632.
  • 36
    Laichalk LL, Bucknell KA, Huffnagle GB et al. Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defence in murine Gram-negative bacterial pneumonia. Infect Immun 1998; 66:28226.
  • 37
    Laichalk LL, Kunkel SL, Strieter RM, Danforth JM, Bailie MB, Standiford TJ. Tumor necrosis factor mediates lung antibacterial host defence in murine Klebsiella pneumoniae. Infect Immun 1996; 64:52118.
  • 38
    Cho N, Seong S, Huh M et al. Expression of chemokine genes in murine macrophages infected with Orientia tsutsugamushi. Infect Immun 2000; 68:594602.